NIDHI SEED Support Scheme NIDHI SSS

You are here

C-CAMP as a NIDHI TBI is calling promising COVID-19 startups to apply for NIDHI4COVID 2.0. It is a specially devised funding initiative carved out by NSTEDB, DST to support development and deployment of new technologies and innovative products/services which would enable our country to fight the on-going war against COVID-19 pandemic more strongly.
 
Current call for Nidhi4Covid 2.0 is open till 31st May, 2021.
 
For more info see - https://dstnidhi4covid.in
To apply see - https://apply.dstnidhi4covid.in/
 
 
C-CAMP has been selected for the National Initiative for Developing and Harnessing Innovations (NIDHI) - Seed Support Scheme (SSS) which is an umbrella programme conceived and developed by the Department of Science & Technology, Government of India, for nurturing ideas and innovations (knowledge-based and technology-driven) into successful startups.  
 

 

Need:
 
To support the “Space, Services and Knowledge” requirements of startups along with the financial support for startups with promising ideas, innovations and technologies in its initial phase. 
To enable some of these incubatee startups to graduate to a next level to raise investments from angel/Venture capitalist or to seek loans from commercial banks/financial institutions.
Thus, positioned to act as a bridge between development and commercialization of innovative technologies/products/services in a relatively hassle-free manner.
 
Objectives:
 
1. To ensure timely availability of the seed support to the deserving incubatee startups, thereby enabling them to take their venture to next level and facilitate towards their success in the market place.
2. To enable the incubator to widen their pipeline of startups and also share the success of their startups in ensuring their long-term operational sustainability.
 
Eligibility:
 
Incubatee should be a registered company in India.
Incubatee has to be an Indian start-up. This support is not meant for Indian Subsidiaries of MNCs/foreign companies. Persons holding Overseas Citizens of India (OCI), Persons of Indian Origin (PIO) would be considered      as Indian citizens for the purpose of this scheme.
The shareholding by Indian promoters in the incubate start up should be at least 51%.
Selected start-up should be/become a resident incubatee of C-CAMP and should have completed three months of incubation at C-CAMP at the time of seed fund investment.
 
Broad Areas and Items to be covered:
 
Performing proof-of concept stage studies
Product development & Prototype generation
Generating additional data or performing validation studies needed to secure next-level funding
Market research 
Hiring of manpower and Professional consultancy
IPR issues
Day-to-day operational Costs
Mentoring
In selected cases, where funds can help with gap funding/next-level funding.
Any other area as deemed necessary and recommended by the Seed Support Management Committee of the incubator.
 
Quantum of funding:
 
Investment support to the tune of Rs. 25 lakhs based on Equity or Equity-linked instruments. However, in few exceptionally deserving startups, the upper limit of seed support to a start-up may be raised to Rs. 100 lakhs.  
 
 
 
For any further information please contact funding@ccamp.res.in 
 
Centre for Cellular and Molecular Platforms,
NCBS-TIFR, GKVK, Bellary Road,
Bangalore 560065, India.
Phone: 91-80-67185055
 
Start-ups funded under NIDHI Seed Support Scheme

SiCureMi Health Technologies Pvt Ltd (Medtech)

SiCureMi is a New Delhi based Healthcare Technology startup which aims to develop an “Intelligent Self Care” product providing personalized care by Signature Cure Using Medical Intelligence (SiCureMi) leveraging the power of data science, machine learning coupled with IoT devices, to analyze, predict, and manage chronic ailments, helping people gain control over their lives. They are developing an innovative and novel approach for predicting the risk of CVD which is different from existing fundus scanning by using OCTA and AI that will provide ophthalmologists and clinicians a risk assessment tool that is easy to interpret and saves time in terms of consultation and identifying the risk.

Website: http://www.sicuremi.com/


Accord Innovations Pvt Ltd (Medical Devices)

Accord Innovations is a Bengaluru based medtech startup developing sustainable technology platform for the early detection of critical illnesses. AKICare device, their first product is a novel and non-invasive method which reduces chances of Hospital acquiring Acute kidney Injury (AKI) by providing multiple functions like Artificial Intelligence and sensor-based system to monitor kidney function on real-time & detect the onset of impending renal dysfunction, Provides an risk assessment to identify the need for intervention & disease progression, Fluid management for evaluating responsiveness to treatment and Accurate AKI staging for monitoring as per KDIGO recommendations.

Website: https://www.accordinnovations.in/


Faunatech Solutions Pvt Ltd (Animal Husbandry)

Faunatech Solutions is a Bengaluru based startup incubated at C-CAMP Bangalore, India. Faunatech was established with a mission to improve the productivity of dairy farmers globally by protecting the health of farm animals using novel diagnostic technologies. Currently, they are in the early commercial stage with four full-time employees. Their first product is a handheld somatic cell count system to detect mastitis in milch cows and buffaloes within 5 min. the technology can detect various stages of mastitis and is ready for pilot deployment. It is an end-to-end solution that helps cooperative managers or farmers to test, analyze and triage for care. The company has so far been funded through private capital from the founders and had raised investment through C-CAMP Beyond Next Ventures Innovation Hub (CBIH) to pursue early market pilots and scale-up of manufacturing.

Website: https://www.faunatechsolutions.com/


Cyclops Medtech Pvt. Ltd. (Medical Devices)

Cyclops Medtech is a Bangalore-based start-up that thrives at the confluence of deep tech and healthcare. They are blending the power of frontier technologies like eye tracking, VR, smart sensors etc. with deep learning to build diagnostic and therapeutic products in the areas of Neurology, Neurotology, Physical Therapy, Audiology and Ophthalmology.

Website: https://www.cyclopsmedtech.com/


Heka Medical Pvt Ltd (Medical Devices)

Heka Medicals India Pvt Ltd is an ISO 13485 & ICMED 13485 Certified company that is already developed an indigenous non-invasive respiratory support system called HekaFlo® which is an “IoT enabled High Flow Nasal Oxygen Therapy Device (HFNO)” for treating hypoxemia in spontaneously breathing patients with warmed and humidified oxygen up to 60LPM to patients. The HFNO technique scores over conventional oxygen therapy as it can tolerate deficiencies of unheated and non-humidified oxygen. It can regulate the temperature and moisture levels to provide greater comfort to infected patients.

Website: https://hekamedicals.com/


CrisprBits Private Limited (Diagnostics)

CrisprBits is pioneering a novel multidisciplinary strategy, crafting solutions rooted in CRISPR technology and synergized with significant advancements in chemistry, computer science, and various engineering fields. The aim is to offer a comprehensive approach to gene editing, effectively translating innovations to practical applications. Presently, the team is utilizing CRISPR for pervasive diagnostics and surveillance tests, addressing critical healthcare needs such as developing next-generation CAR-T cells and disease tissue models. The initial iteration, PathCrisp, focuses on identifying infectious pathogens and antimicrobial resistance (AMR) genes within the ICU. Additionally, extending CRISPR applications into the food and fermentation industries to tackle climate-related challenges is underway.

Website: https://crisprbits.com/


Sekkei Bio Pvt Ltd (Drug Discovery)

Sekkei Bio Private Limited is an innovation-driven biopharmaceutical company focused on developing new-age medicines to address global unmet needs. Their proprietary computational platform combines AI and physics for multi-targeted drug design, targeting diseases like diabetes, obesity, and cardiovascular conditions. Sekkei Bio is developing next-generation vaccines and therapeutics using circular RNA, which offers advantages in stability and delivery. Sekkei Bio is pioneering advanced drug delivery systems to overcome challenges like enzymatic degradation and poor membrane permeability, aiming to deliver peptides orally

Website: https://sekkeibio.com/


Sepio Health Pvt Ltd (Agri and allied)

Dr. Praveen Vemula is developing novel biomaterials to solve unmet clinical needs. Currently, he is developing a dermal cream to prevent chronic pesticide exposure in farmers. He has generated stellar preclinical data using our technology. He has two formulations to prevent pesticide-induced toxicity. He has developed a dermal/topical gel to prevent dermal exposure of MPT. Additionally, he is developing an active face mask which can deactivate pesticides to prevent pesticide-exposure through nasal route.

Website: https://sepio-health.com/